Shanghai, China

Jason Christopher Wong


 

Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2010-2023

Loading Chart...
Loading Chart...
8 patents (USPTO):

Title: Innovations by Jason Christopher Wong: Pioneering Treatments for Respiratory Syncytial Virus

Introduction

Jason Christopher Wong, located in Shanghai, China, is a prominent inventor with a notable portfolio of eight patents. His work focuses primarily on pharmaceutical innovations, particularly in the treatment and prevention of respiratory syncytial virus (RSV) disease. His contributions to this field are expected to make significant advancements in medical science.

Latest Patents

Wong's latest patents revolve around compounds specifically formulated for the treatment and prophylaxis of respiratory syncytial virus disease. These patents include a compound of formula (I), along with its pharmaceutically acceptable salts, where various components such as R, A, Q, X, and Y are meticulously defined within the specifications and claims. These innovations pave the way for new pharmaceutical treatments aimed at combating RSV disease.

Career Highlights

Currently, Jason Wong contributes his expertise to Hoffmann-La Roche Inc., a leading pharmaceutical company known for its commitment to innovation in health care. His career is marked by an unwavering dedication to developing effective therapeutic solutions, reflecting his status as a key figure in his field.

Collaborations

Throughout his career, Wong has collaborated with esteemed colleagues such as Xihan Wu and Guozhi Tang. These collaborations enhance the innovative potential of his projects and signify a strong teamwork approach in tackling pressing health challenges.

Conclusion

Jason Christopher Wong is a pioneering inventor whose work focuses on vital advancements in the treatment of respiratory syncytial virus disease. With a total of eight patents, his contributions through Hoffmann-La Roche Inc. exemplify the importance of innovation in the pharmaceutical industry. His collaborations with notable colleagues further enrich the impact of his work, promising a brighter future for medical treatments targeting RSV.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…